Acute Coronary Syndrome Clinical Trials in Atlanta, Georgia
2 recruitingAtlanta, Georgia
Showing 1–2 of 2 trials
Recruiting
Phase 3
Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS
Acute Coronary Syndrome
DalCor Pharmaceuticals2,000 enrolled223 locationsNCT05918861
Recruiting
AngelMed Guardian® System PMA Post Approval Study
Acute Coronary Syndrome
Angel Medical Systems500 enrolled18 locationsNCT05412927